Εμφάνιση απλής εγγραφής

dc.creatorMantzarlis K., Deskata K., Papaspyrou D., Leontopoulou V., Tsolaki V., Zakynthinos E., Makris D.en
dc.date.accessioned2023-01-31T08:56:58Z
dc.date.available2023-01-31T08:56:58Z
dc.date.issued2022
dc.identifier10.3390/antibiotics11081053
dc.identifier.issn20796382
dc.identifier.urihttp://hdl.handle.net/11615/76299
dc.description.abstractIt is widely known that blood stream infections (BSIs) in critically ill patients may affect mortality, length of stay, or the duration of mechanical ventilation. There is scarce data regarding blood stream infections in mechanically ventilated COVID-19 patients. Preliminary studies report that the number of secondary infections in COVID-9 patients may be higher. This retrospective analysis was conducted to determine the incidence of BSI. Furthermore, risk factors, mortality, and other outcomes were analyzed. The setting was an Intensive Care Unit (ICU) at a University Hospital. Patients suffering from SARS-CoV-2 infection and requiring mechanical ventilation (MV) for >48 h were eligible. The characteristics of patients who presented BSI were compared with those of patients who did not present BSI. Eighty-four patients were included. The incidence of BSI was 57%. In most cases, multidrug-resistant pathogens were isolated. Dyslipidemia was more frequent in the BSI group (p < 0.05). Moreover, BSI-group patients had a longer ICU stay and a longer duration of both mechanical ventilation and sedation (p < 0.05). Deaths were not statistically different between the two groups (73% for BSI and 56% for the non-BSI group, p > 0.05). Compared with non-survivors, survivors had lower baseline APACHE II and SOFA scores, lower D-dimers levels, a higher baseline compliance of the respiratory system, and less frequent heart failure. They received anakinra less frequently and appropriate therapy more often (p < 0.05). The independent risk factor for mortality was the APACHE II score [1.232 (1.017 to 1.493), p = 0.033]. © 2022 by the authors.en
dc.language.isoenen
dc.sourceAntibioticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85137340268&doi=10.3390%2fantibiotics11081053&partnerID=40&md5=31ba2f736c24c6027ffaf370b7852f7f
dc.subjectanakinraen
dc.subjectremdesiviren
dc.subjecttocilizumaben
dc.subjectAcinetobacter baumanniien
dc.subjectageden
dc.subjectArticleen
dc.subjectartificial ventilationen
dc.subjectbloodstream infectionen
dc.subjectbronchoscopyen
dc.subjectchronic lung diseaseen
dc.subjectcolonoscopyen
dc.subjectcontrolled studyen
dc.subjectcoronavirus disease 2019en
dc.subjectdiabetes mellitusen
dc.subjectdyslipidemiaen
dc.subjectEnterococcusen
dc.subjectfemaleen
dc.subjectgastroscopyen
dc.subjectheart failureen
dc.subjectHorowitz indexen
dc.subjecthospitalizationen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectincidenceen
dc.subjectischemic heart diseaseen
dc.subjectKlebsiella pneumoniaeen
dc.subjectlength of stayen
dc.subjectlymphocyte counten
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmortalityen
dc.subjectprevalenceen
dc.subjectprospective studyen
dc.subjectProteus mirabilisen
dc.subjectrisk factoren
dc.subjectSequential Organ Failure Assessment Scoreen
dc.subjectSerratia marcescensen
dc.subjectStenotrophomonas maltophiliaen
dc.subjectMDPIen
dc.titleIncidence and Risk Factors for Blood Stream Infection in Mechanically Ventilated COVID-19 Patientsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής